Related Experiment Video
Updated: Dec 15, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Hereditary C1 inhibitor deficiency associated with systemic lupus erythematosus
1Niruj Rheumatology Clinic, Ahmedabad, Gujarat, India.
Insights
A family with hereditary C1 inhibitor deficiency and a SERPING-1 gene mutation shows a link between this deficiency and juvenile-onset systemic lupus erythematosus (SLE) and hereditary angioedema. This genetic link offers new insights into these autoimmune and autoinflammatory conditions.
Area of Science:
- Genetics and Immunology
- Autoimmune Diseases
- Rare Genetic Disorders
Background:
- Hereditary angioedema is a rare genetic disorder characterized by recurrent swelling episodes.
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs.
- C1 inhibitor deficiency is a known cause of hereditary angioedema.
Observation:
- A family presented with juvenile-onset SLE in two children and hereditary angioedema in the father.
- All affected individuals carried a frameshift mutation in the SERPING-1 gene, leading to low C1 inhibitor levels.
- The children exhibited SLE symptoms including nephritis, while the father had angioedema and abdominal pain.
Findings:
- The study identified a novel frameshift mutation in the SERPING-1 gene in affected family members.
- This mutation was associated with both hereditary angioedema and juvenile-onset SLE phenotypes within the same family.
- The findings suggest a potential genetic link between C1 inhibitor deficiency and SLE.
Implications:
- This research highlights a potential genetic overlap between hereditary angioedema and systemic lupus erythematosus.
- Understanding this link may lead to improved diagnostic strategies and targeted therapies for patients with these conditions.
- Further research into the role of C1 inhibitor in SLE pathogenesis is warranted.
Abstract:
Here, we report a family with two children (the elder son and younger daughter) diagnosed with juvenile-onset systemic lupus erythematosus (SLE) and the father diagnosed with hereditary angioedema. Serum C1 inhibitor (C1-INH) levels were low, and clinical exome next-generation sequencing detected a frameshift mutation in the SERPING-1 gene in all three patients. The mother had neither of the clinical phenotypes. The son had cutaneous symptoms, fever and polyarthralgia, along with lupus nephritis, and thus required rituximab therapy as well as mycophenolate mofetil and low-dose steroids to control disease activity. The daughter had a milder disease, with cutaneous manifestation, fever and polyarthralgia, and which was controlled with mycophenolate mofetil, hydroxychloroquine and low-dose steroids. Both children had never experienced angioedema. The father had a long history of self-limiting, non-life-threatening irregular episodes of subcutaneous angioedema and abdomen pain. He was not on any regular medication for these symptoms. We searched the literature for evidence of hereditary C1-INH deficiency associated with monogenic SLE or SLE-like-phenotype.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Cohesins
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Complement System
Nephrotic Syndrome I : Introduction

